The Translational Immunomics in Hematological Neoplasms Group, led by Dr. Bruno Paiva at CIMA Universidad de Navarra (Pamplona, Spain), is looking for a highly motivated PhD student to join our team.
The translational model that governs our group is based on the hybrid nature of our flow cytometry laboratory, with its dual focus on diagnosis and research. First, we conduct research to improve the methods we use for the differential diagnosis, staging, and monitoring of patients with hematological malignancies. Second, our goal is to understand the biology of the tumor cells that we routinely detect in diagnostic settings (e.g., circulating tumor cells [CTCs], measurable residual disease [MRD], and immune monitoring).
Our laboratory is recognized for its leadership in translational research across the spectrum of monoclonal gammopathies. Our most notable scientific contributions are, as expected, in the clinical application of flow cytometry.



Although multiple myeloma is the tumor we have studied most extensively (>150 publications in leading hematology journals over the past 10 years), we have also defined the clinical utility of flow cytometry in other malignancies, such as primary systemic amyloidosis (Paiva, Blood ; Paiva, Blood ; Puig, Leukemia ) and Waldenström macroglobulinemia (Paiva, Leukemia ; Paiva, Blood ).
In terms of innovative research in immunogenomics, within the field of multiple myeloma, we have contributed to advancing the field of clonal hematopoiesis (Maia, Blood ) and lymphopoiesis (Rodriguez, ASH ), monitoring of circulating tumor cells (CTCs) (Garces, J Clin Oncol ; Termini, Clin Cancer Res ), and the biology of clonal dissemination (Paiva, Blood ; Mishima, Cell Rep ; Garces, Leukemia [2]); measurable residual disease (MRD) monitoring (>15 publications in, for example, J Clin Oncol and Blood); and the biology of resistant clones (Paiva, Blood ; Goicoechea, Blood ), immune profiling (Paiva, Blood [2]; Botta, Blood Adv ; Termini, Clin Cancer Re

📌 Phd Position: Translational Immunomics In Hematological Neoplasms Group (España)
🏢 CIMA; Universidad de Navarra
📍 España